{"id":2020,"date":"2017-12-31T00:00:32","date_gmt":"2017-12-30T17:00:32","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=2020"},"modified":"2022-03-30T10:05:48","modified_gmt":"2022-03-30T03:05:48","slug":"a-phase-iii-open-label-study-to-evaluate-switching-from-a-tdf-containing-combination-regimen-to-a-taf-containing-combination-single-tablet-regimen-str-in-virologically-suppressed-hiv-1-positive-su","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/2020\/","title":{"rendered":"A phase 3, open-label study to evaluate switching from a TDF-containing combination regimen to a TAF-containing combination single tablet regimen (STR) in virologically-suppressed, HIV-1 positive subjects"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Randomized, open-label, multicenter,\nactive-controlled study to evaluate the safety and efficacy of virologically\nsuppressed subjects who switch from a FTC\/TDF regimen to tenofovir alafenamide\n(TAF)-containing regimen in achieving HIV-1 RNA &lt; 50 copies\/mL at Week 48 as\ndefined by the FDA snapshot analysis in HIV-1 infected subjects.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tRandomized, open-label, multicenter, active-controlled study to evaluate the safety and efficacy of virologically suppressed subjects who switch from a FTC\/TDF regimen to tenofovir alafenamide (TAF)-containing regimen in achieving HIV-1 RNA < 50 copies\/mL at Week 48 as defined by the FDA snapshot analysis in HIV-1 infected subjects.\t\t\n<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-2020","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=2020"}],"version-history":[{"count":1,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2020\/revisions"}],"predecessor-version":[{"id":3339,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2020\/revisions\/3339"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=2020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=2020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=2020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}